Image: Shutterstock
Updated: FDA approves weight loss drug Wegovy to reduce cardiovascular events
The FDA on Friday expanded the label for Novo Nordisk’s popular weight loss injection Wegovy, approving it as a treatment to reduce the risk of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
